{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:46:15Z","timestamp":1755218775053,"version":"3.43.0"},"reference-count":29,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Dry eye disease (DED) is a common condition, especially among the elderly. Artificial tears are formulated to relieve the symptoms of DED. However, selecting the most suitable option can be challenging, as the products differ in various aspects, including eligibility for reimbursement, pricing, packaging formats, composition, and presence of preservatives. This review provides a comprehensive overview of artificial tear products available in Denmark, highlighting differences in their preservative content and reimbursement eligibility, to support more personalized and effective management of DED.<\/jats:p>","DOI":"10.61409\/v11240799","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T08:54:08Z","timestamp":1746176048000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Toxic preservatives in artificial tears"],"prefix":"10.61409","volume":"185","author":[{"given":"Christian Eggers \u00d8stergaard","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrine Najah","family":"Mikha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umalbaninn Mokdad Kasem","family":"Alnoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid Dissing","family":"Sj\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaynab Ahmad","family":"Mouhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Kolko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"ref0","unstructured":"Johansen S. T\u00f8rre \u00f8jne - et irritationsmoment for mange \u00e6ldre. https:\/\/ojenforeningen.dk\/artikler\/toerre-oejne-irritationsmoment-mange-aeldre (feb 2025)"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Craig JP, Nelson JD, Azar DT et al. TFOS DEWS II Report Executive Summary. Ocul Surf. 2017;15(4):802-812. https:\/\/doi.org\/10.1016\/j.jtos.2017.08.003","DOI":"10.1016\/j.jtos.2017.08.003"},{"key":"ref2","unstructured":"Heegaard S, Knudsen LL, van Setten G et al. Dry eye disease. Nordic Guidelines Second Edition 2002. Dansk Oftalmologisk Selskab, 2022. https:\/\/dansk-oftalmologisk-selskab.dk\/wp-content\/uploads\/2022\/06\/2022-11-03-Nordic-Guideline.pdf (feb 2025)"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Baudouin C, Labbe A, Liang H et al. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312-34. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.03.001","DOI":"10.1016\/j.preteyeres.2010.03.001"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Kolko M, Gazzard G, Baudouin C et al. Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment. Ocul Surf. 2023;29:456-468. https:\/\/doi.org\/10.1016\/j.jtos.2023.05.012","DOI":"10.1016\/j.jtos.2023.05.012"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Walsh K, Jones L. The use of preservatives in dry eye drops. Clin Ophthalmol. 2019;13:1409-1425. https:\/\/doi.org\/10.2147\/OPTH.S211611","DOI":"10.2147\/OPTH.S211611"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Labetoulle M, Benitez-Del-Castillo JM, Barabino S et al. Artificial tears: biological role of their ingredients in the management of dry eye disease. Int J Mol Sci. 2022;23(5):2434. https:\/\/doi.org\/10.3390\/ijms23052434","DOI":"10.3390\/ijms23052434"},{"key":"ref7","unstructured":"Lin Z, Liu X, Zhou T et al. A mouse dry eye model induced by topical administration of benzalkonium chloride. Mol Vis. 2011;17:257-64."},{"key":"ref8","unstructured":"Coroi MC, Bungau S, Tit M. Preservatives from the eye drops and the ocular surface. Rom J Ophthalmol. 2015;59(1):2-5."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Goldstein MH, Silva FQ, Blender N et al. Ocular benzalkonium chloride exposure: problems and solutions. Eye (Lond). 2022;36(2):361-368. https:\/\/doi.org\/10.1038\/s41433-021-01668-x","DOI":"10.1038\/s41433-021-01668-x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Kaur IP, Lal S, Rana C et al. Ocular preservatives: associated risks and newer options. Cutan Ocul Toxicol. 2009;28(3):93-103. https:\/\/doi.org\/10.1080\/15569520902995834","DOI":"10.1080\/15569520902995834"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Mantelli F, Tranchina L, Lambiase A, Bonini S. Ocular surface damage by ophthalmic compounds. Curr Opin Allergy Clin Immunol. 2011;11(5):464-70. https:\/\/doi.org\/10.1097\/ACI.0b013e32834a95c9","DOI":"10.1097\/ACI.0b013e32834a95c9"},{"key":"ref12","unstructured":"Debbasch C, Brignole F, Pisella PJ et al. Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci. 2001;42(3):642-52."},{"key":"ref13","unstructured":"Clouzeau C, Godefroy D, Riancho L et al. Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro. Mol Vis. 2012;18:851-63."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Datta S, Baudouin C, Brignole-Baudouin F et al. The eye drop preservative benzalkonium chloride potently induces mitochondrial dysfunction and preferentially affects LHON mutant cells. Invest Ophthalmol Vis Sci. 2017;58(4):2406-2412. https:\/\/doi.org\/10.1167\/iovs.16-20903","DOI":"10.1167\/iovs.16-20903"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Vitoux MA, Kessal K, Parsadaniantz SM et al. Benzalkonium chloride-induced direct and indirect toxicity on corneal epithelial and trigeminal neuronal cells: proinflammatory and apoptotic responses in vitro. Toxicol Lett. 2020;319:74-84. https:\/\/doi.org\/10.1016\/j.toxlet.2019.10.014","DOI":"10.1016\/j.toxlet.2019.10.014"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Martone G, Frezzotti P, Tosi GM et al. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. Am J Ophthalmol. 2009;147(4):725-735 e1. https:\/\/doi.org\/10.1016\/j.ajo.2008.10.019","DOI":"10.1016\/j.ajo.2008.10.019"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Hedengran A, Kolko M. The molecular aspect of anti-glaucomatous eye drops - are we harming our patients? Mol Aspects Med. 2023;93:101195. https:\/\/doi.org\/10.1016\/j.mam.2023.101195","DOI":"10.1016\/j.mam.2023.101195"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Brignole-Baudouin F, Riancho L, Liang H, Baudouin C. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells. Curr Eye Res. 2011;36(11):979-88. https:\/\/doi.org\/10.3109\/02713683.2011.578781","DOI":"10.3109\/02713683.2011.578781"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Brignole-Baudouin F, Riancho L, Liang H et al. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost\/timolol fixed combination and latanoprost\/timolol fixed combination. J Ocul Pharmacol Ther. 2011;27(3):273-80. https:\/\/doi.org\/10.1089\/jop.2010.0111","DOI":"10.1089\/jop.2010.0111"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Hedengran A, Freiberg JC, Hansen PM et al. Generic benzalkonium chloride-preserved travoprost eye drops are not identical to the branded polyquarternium-1-preserved travoprost eye drop: effect on cultured human conjunctival goblet cells and their physicochemical properties. Acta Ophthalmol. 2022;100(7):819-827. https:\/\/doi.org\/10.1111\/aos.15163","DOI":"10.1111\/aos.15163"},{"key":"ref21","unstructured":"Paimela T, Ryhanen T, Kauppinen A et al. The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells. Mol Vis. 2012;18:1189-96."},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Bron AJ, Daubas P, Siou-Mermet R, Trinquand C. Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears. Eye (Lond). 1998;12 (pt 5):839-47. https:\/\/doi.org\/10.1038\/eye.1998.215","DOI":"10.1038\/eye.1998.215"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Meloni M, Pauly A, De Servi B et al. Occludin gene expression as an early in vitro sign for mild eye irritation assessment. Toxicol In Vitro. 2010;24(1):276-85. https:\/\/doi.org\/10.1016\/j.tiv.2009.08.016","DOI":"10.1016\/j.tiv.2009.08.016"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Niro A, Pignatelli F, Fallico M et al. Polyhexamethylene biguanide hydrochloride (PHMB)-properties and application of an antiseptic agent. A narrative review. Eur J Ophthalmol. 2022:11206721221124684. https:\/\/doi.org\/10.1177\/11206721221124684","DOI":"10.1177\/11206721221124684"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Kim SH, Jo SH, Kim BK, Park SH. Tissue engineered mini-cornea model for eye irritation test. Tissue Eng Regen Med. 2023;20(2):213-223. https:\/\/doi.org\/10.1007\/s13770-022-00504-x","DOI":"10.1007\/s13770-022-00504-x"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Wang J, Liu Y, Kam WR et al. Toxicity of the cosmetic preservatives parabens, phenoxyethanol and chlorphenesin on human meibomian gland epithelial cells. Exp Eye Res. 2020;196:108057. https:\/\/doi.org\/10.1016\/j.exer.2020.108057","DOI":"10.1016\/j.exer.2020.108057"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Jaenen N, Baudouin C, Pouliquen P et al. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol. 2007;17(3):341-9. https:\/\/doi.org\/10.1177\/112067210701700311","DOI":"10.1177\/112067210701700311"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Xu M, Sivak JG, McCanna DJ. Comparison of the effects of ophthalmic solutions on human corneal epithelial cells using fluorescent dyes. J Ocul Pharmacol Ther. 2013;29(9):794-802. https:\/\/doi.org\/10.1089\/jop.2013.0002","DOI":"10.1089\/jop.2013.0002"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:02:18Z","timestamp":1754481738000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V11240799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":29,"URL":"https:\/\/doi.org\/10.61409\/v11240799","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2025,4,7]]}}}